---
title: "IART SEC Filings and Financial Statements | Tradytics"
description: "Annual income statements, balance sheets and cash flows for Integra LifeSciences (IART), with links to the SEC filings."
url: "https://tradytics.com/research/IART/fundamentals"
image: "https://tradytics.com/api/v2/og/research.png?id=IART&v=stock-11994864"
---

# IART financial statements and SEC filings

## IART annual income statement

| Fiscal period end | Revenue | Operating income | Net income | SEC filing |
| --- | --- | --- | --- | --- |
| 2025-12-31 | $1.64B | -$493.37M | -$516.47M | [10-K](https://www.sec.gov/Archives/edgar/data/917520/000091752026000011/0000917520-26-000011-index.htm) |
| 2024-12-31 | $1.61B | $28.41M | -$6.94M | [10-K](https://www.sec.gov/Archives/edgar/data/917520/000091752026000011/0000917520-26-000011-index.htm) |
| 2023-12-31 | $1.54B | $111.53M | $67.74M | [10-K](https://www.sec.gov/Archives/edgar/data/917520/000091752026000011/0000917520-26-000011-index.htm) |
| 2022-12-31 | $1.56B | $238.92M | $180.55M | [10-K](https://www.sec.gov/Archives/edgar/data/917520/000091752025000017/0000917520-25-000017-index.htm) |
| 2021-12-31 | $1.54B | $197.23M | $169.07M | [10-K](https://www.sec.gov/Archives/edgar/data/917520/000091752024000022/0000917520-24-000022-index.htm) |
| 2020-12-31 | $1.37B | $151.37M | $133.89M | [10-K](https://www.sec.gov/Archives/edgar/data/917520/000091752023000015/0000917520-23-000015-index.htm) |

## IART annual balance sheet

| Fiscal period end | Assets | Liabilities | Equity | SEC filing |
| --- | --- | --- | --- | --- |
| 2025-12-31 | $3.60B | $2.56B | $1.04B | [10-Q](https://www.sec.gov/Archives/edgar/data/917520/000091752026000077/0000917520-26-000077-index.htm) |
| 2024-12-31 | $4.04B | $2.49B | $1.55B | [10-K](https://www.sec.gov/Archives/edgar/data/917520/000091752026000011/0000917520-26-000011-index.htm) |
| 2023-12-31 | $3.78B | $2.19B | $1.59B | [10-K](https://www.sec.gov/Archives/edgar/data/917520/000091752025000017/0000917520-25-000017-index.htm) |
| 2022-12-31 | $3.89B | $2.09B | $1.80B | [10-K](https://www.sec.gov/Archives/edgar/data/917520/000091752024000022/0000917520-24-000022-index.htm) |
| 2021-12-31 | $3.78B | $2.10B | $1.68B | [10-K](https://www.sec.gov/Archives/edgar/data/917520/000091752023000015/0000917520-23-000015-index.htm) |
| 2020-12-31 | $3.62B | $2.10B | $1.51B | [10-K](https://www.sec.gov/Archives/edgar/data/917520/000091752022000010/0000917520-22-000010-index.htm) |

## IART annual cash flow

| Fiscal period end | Operating cash flow | Capital expenditure | Financing cash flow | SEC filing |
| --- | --- | --- | --- | --- |
| 2025-12-31 | $50.38M | -$81.44M | $28.34M | [10-K](https://www.sec.gov/Archives/edgar/data/917520/000091752026000011/0000917520-26-000011-index.htm) |
| 2024-12-31 | $129.38M | -$104.42M | $237.86M | [10-K](https://www.sec.gov/Archives/edgar/data/917520/000091752026000011/0000917520-26-000011-index.htm) |
| 2023-12-31 | $139.96M | -$66.86M | -$229.93M | [10-K](https://www.sec.gov/Archives/edgar/data/917520/000091752026000011/0000917520-26-000011-index.htm) |
| 2022-12-31 | $264.47M | -$42.34M | -$251.95M | [10-K](https://www.sec.gov/Archives/edgar/data/917520/000091752025000017/0000917520-25-000017-index.htm) |
| 2021-12-31 | $312.43M | -$48.02M | -$98.23M | [10-K](https://www.sec.gov/Archives/edgar/data/917520/000091752024000022/0000917520-24-000022-index.htm) |
| 2020-12-31 | $203.83M | -$38.89M | $121.62M | [10-K](https://www.sec.gov/Archives/edgar/data/917520/000091752023000015/0000917520-23-000015-index.htm) |

- [IART stock research](https://tradytics.com/research/IART)
- [IART financial summary](https://tradytics.com/research/IART/financials)
- [Read the data without JavaScript](https://tradytics.com/research/IART/fundamentals?snapshot=1)
